Framework for Risk Assessment Flashcards

1
Q

Risk Assessment Framework

5

A
  1. Problem Formulation
  2. Hazard Identification
  3. Dose-Response Assessment
  4. Exposure Assessment
  5. Risk Characterization

PHEDR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the main goal of problem formulation?

A

to figure out the technical and analytical approach

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Subgoals of problem formulation

A

Goals:
1. Identify issues to be assessed
1. Identify goals, breadth, depth, and focus of risk assessment (like scope & limitations)
1. Establishes who the decision maker, stakeholders, risk assessor are

what, so what, who

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Differentiate

Problem Formulation - Outputs

2

A

Conceptual model
* Taken from literature
* environmental stressors, pathways, sources, populations at risk, potential adverse effects

Analysis plan
* how to locate pollution data
* What chemicals of concern
* How to assess & measure doses, exposures
* what risk metrics to use
* Other technical requirements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Importance of Problem Formulation 3

A
  1. Ensure commitment of stakeholders & decision makers
  2. Better chance of finding acceptable policy solution
    * Stakeholders & DMs should be in process from very beginning — some sort of ownership on the decision
  3. Save time and resources
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Explain the main challenge of Problem Formulation

A
  • Need to balance extensive dialogue & practical efficiency
  • Can take away time
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Hazard Identification - Goal

A

to understand the extent of harm caused by a specific hazard

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Hazard Identification - 4 subgoals

A
  1. determine adverse effects related to exposure
  2. do an RRL - choose from data & evaluate supporting scientific evidence (maganda ba)
  3. produce a list of potential toxic effects - so people know wtf is going on
  4. establish causation - describe nature & strength
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

List

Hazard Identification - Sources of Evidence

4

A
  1. Epidemiology
  2. Toxicology
  3. In-vitro studies
  4. In-silico studies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe

Epidemiology as a Source of Evidence for Hazard Identification

A
  • observational human studies
  • Mostly observational, about correlations
    * No controlling of variables/experimenting
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Toxicology as a Source of Evidence for Hazard Identification

A

experimental animal evidence
* More definitive causation
* Arguments surrounding testing on animals
* Concerned w/ symptoms & doses
* we shifted towards this bc it’s unethical to do it on humans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

In-vitro studies as a Source of Evidence for Hazard Identification

A

in-vitro studies – cell-based studies
* Eg. Ivermectin – tested on a petri dish
* Principle of emergent property: cell acting different outside of its system
* Works well for dermal absorption properties – Estee Lauder is leaning more towards in-vitro testing now

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Define

Principle of emergent property

A

cell acting different outside of its system

it gains the property when it works with other components in a system, however the property does not manifest when the cell is by itself.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

In silico stu stud as a Source of Evidence for Hazard Identification

A

computer modelling
* How a variant can mutate
* How substances will be stored, excreted etc. in & from body

Note Garbage in, garbage out – data should be quality to get quality conclusions
* Eg. MMDA claimed to have models that helped in their decision making, & their outputs were always crap – maam questions the data of MMDA
* Still needs data from other fields

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is assessed during Hazard Identification?

5

A
  • Contaminants, its degradation products, and metabolites
  • Determinants of toxicity
  • Adverse health effects – typically broad
  • Characterization based on effects, target organs, and mode of action
  • Weight of evidence analysis

wadcc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

List

Determinants of hazards’ toxicity

6

A
  1. Level, frequency, and duration of dose/exposure
  2. Demographic of exposed populations
  3. Routes of exposure
  4. Absorption and metabolism of contaminants
  5. Physical form of contaminant
  6. Presence of other contaminants (synergistic or additive effects)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Describe

Adverse health effects

A
  • usually broad

Includes
1. Overt diseases (cancer, birth defects)
1. More subtle biological effects (alterations in gene expression)
1. Upstream effects - effects that can play an early role leading to disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Define

Upstream effect

A

effects that can play an early role in leading to disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Biological endpoint

A
  • A direct marker of disease progression;
  • Describes health effects (or probability of health effects) from exposure to a hazard
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Define

mode of action

A

how substance affects the target cell or organs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Define

Weight of evidence analysis

A

judgment on whether the body of evidence available supports the conclusion that a substance is a hazard to humans

  • Assess which ones to follow/not follow
  • Look at methodology & method of analysis
  • Ex. cigarettes: tobacco is organic, formaldehyde is preservative, tar is carcinogen, nicotine is stimulant
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Importance of Hazard Identification

A
  1. High quality scientific studies = best evidence
  2. Human data is the gold standard
  3. Use of Epidemiological studies
  4. Use of Toxicological studies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Issue w/ High quality scientific studies

A

best evidence, BUT
1. Not always available
2. Design and methodological limitations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Issue w/ Human data
1. Use of Epidemiological studies
1. Use of Toxicological studies

A

Studies examine occupational populations not representative of general population

aka, Done on healthier humans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Issue w/ Use of Epidemiological studies

A
  1. Limited by uncertainties on amount and duration of exposure;
  2. Presence of potential confounders
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Issue w/ Use of Toxicological studies

A

Challenge of determining relevance to humans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

List

Dose-Response Assessment Goals

2

A
  • Characterize relationship between dose & adverse effect
  • To estimate toxicity values, the dose makes the poison
    *
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Define adverse effects

A

likelihood/severity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

How do we characterize dose & adverse effect?

A

Mathematical models: Dose-Response Relationship
For each adverse effect
To pinpoint with effect will come out first

30
Q

Explain
The dose makes the poison, and provide examples

A

Impt to estimate toxicity values bc everything can be poison given the right amount

Ex
* rashes from sun poisoning
* too much oxygen → go blind
* too much water → ??? i forgot

31
Q

Differentiate
Carcinogen vs noncarcinogen

A

Carcinogens
* Mode are assumed to have no threshold
* aka all levels have some risk
* Ex. asbestos, PAHs

Noncarcinogens
* act in relation to a threshold
* low levels may occur without adverse effects
* Some concentrations will be okay, /then/ adverse effects happen
* Ex. pollen, dust, asthma

Both
* after biological threshold, ↑ exposure = ↑ severity of adverse effect

32
Q

How do we estimate toxicity values?

A

At what dose makes adverse effects start

33
Q

T/F
We are 100% sure that noncarcinogens are noncarcinogens

A

F
* we are never really sure until someone gets cancer!

34
Q

Which thresholds exist for carcinogens? How are they used?

A
  • Model is fit to available data → derive slope of dose response curve
  • Cancer slope factor (CSF) or unit cancer risk (UCR) is derived from slope
  • With exposure data, CSF is used to characterize risk
35
Q

Which thresholds exist for noncarcinogens? How are they used?

A
  • NOAEL: no observed adverse effect level or
  • LOAEL: lowest observed adverse effect

NOAEL & LOAEL are used as a point of departure (POD) for extrapolation for reference dose (RfD)
* Used with exposure data to characterize risk

36
Q

Define
RfD

A

reference dose
* dose without risk if chemical exposure occurs over a human lifetime

37
Q

What is the value for Uncertainty Factors Values

A

Value of 10 for interspecies & intraspecies extrapolation

38
Q

Differentiate
Interspecies vs Intraspecies extrapolation

A

Interspecies
* NOAEL from animal studies
* We favor some animals over others bc of extrapolation factor
* Farther it is = more extrapolation

Intraspecies extrapolation
* accounts for natural variability in response in human populations

39
Q

What is an additonal factor for sensitive/vulnerable populations

A

RfD = (NOAEL / uncertainty factors)

RfD: reference dose

40
Q

What are the issues with thresholds for carcinogens & noncarcinogens?

A

Scientific evidence suggests contrary shit:
* Noncarcinogens do not always have a threshold
* Carcinogens may have a threshold

“Carcinogenicity” determined to vary widely

41
Q

What is a possible solution for issues regarding thresholds for carcinogens & noncarcinogens?

A

Use benchmark dose (BMD) to replace NOAEL/LOAEL
* BMD: estimate of dose at which a specific increase in adverse effect (aka BMR) is apparent
* BMR: benchmark response

42
Q

List
Important threshold variables (carcinogens & noncarcinogens)
2 carci+ 4 non + bonus 2

A

CSF - cancer slope factor
UCR - unit cancer risk
NOAEL - no observed adverse effect level
LOAEL - lowest observed adverse effect level
POD - point of departure
RfD - reference dose

New:
BMD - benchmark dose
BMR - benchmark response

43
Q

Define
Exposure assessment

A

to identify actual or likely exposure/dose in a given population

44
Q

List
Goals for Exposure Assessment
3

A

(1) Calculate and estimate potential exposures
(2) Determine concentration of substance of interest
(3) Describes substance and exposed population

45
Q

How does Exposure Assessment calculate and estimate potential exposures?

A
  • identifies heaviest/most likely exposure pathway
  • Informs you for management strategies
46
Q

Which aspects of the substance are described whe doing an Exposure Assessment?

A
  • magnitude
  • duration
  • timing
  • route of exposure
47
Q

Which aspects of the **exposed population **are described whe doing an Exposure Assessment?

A
  • size
  • nature
  • categories
48
Q

Differentiate
Exposure vs Dose

A

Exposure: chemical contact on outer boundary of the person
Dose: amount of chemical taken in the body
Note:
* Sometimes dose < exposure
* Not likely na dose = exposure

49
Q

List
Categories for Identifying Information
4

A
  1. Characterizing exposure setting
  2. Identify exposure pathways
  3. Quantify exposure (magnitude, frequency, duration)
  4. Quantify potential human intake
50
Q

T/F
Our main exposure pathways are the dermal, mucosal pathways, as well as our private parts

A

Private parts not really

51
Q

How do we quantify exposure?
3

A
  1. magnitude
  2. frequency
  3. duration
52
Q

Unit for quantifying potential human intake

A

unit body weight per unit time
mg/kg-BW/day

  • mg/kg - unit
  • BW - body weight
  • /day - Per unit time
53
Q

Differentiate
2 types of exposure

A

Acute: bursts
* relatively short period of time

Chronic: Tends to be continuous
* long periods of time, pwede pang lifetime

54
Q

List
Exposure Characterization Methods (Exposure Assessment)
6

A
  1. Direct/Indirect measurements
  2. Surveys
  3. Biomonitoring
  4. Modeling
  5. Average Daily Dose (ADD)
  6. Lifetime Average Daily Dose (LADD)
    DBSMAL
55
Q

Differentiate
Direct vs Indirect measurements

A

Direct: directly measure
* Actual frequency, intensity, and/or duration

Indirect: use an indirect metric
* Sampling air, water, soil, or food products
* number of headaches from fumes

56
Q

What kinds of surveys show Exposure Characterization Methods?
What issues arise from surveys?

A
  • actual/hypothetical habits involving a particular exposure pathway
  • Problem: people overreport or underreport – produces uncertainty
57
Q

How is biomonitoring an Exposure Characterization Method?

A
  • we take Biological samples/biomarkers (Blood, hair, urine, fecal matter, etc)
  • also measure concentrations of substances or metabolites (But metabolites dont stay in the body for a long time)
58
Q

How is Modelling an Exposure Characterization Method?

A
  • Math modeling can estimate hypothetical exposure
  • Ex. COVID particles travelling in a bus wow p6)
59
Q

Identify & Differentiate
ADD vs LADD

A

Average Daily Dose (ADD)
* Estimate of average daily dose level
* acute/subchronic/chronic?
* For non-cancer endpoints

Lifetime Average Daily Dose (LADD)
* Estimate of average daily over a person’s lifetime
* Lifetime exposure for both cancer and non-cancer endpoints
We are obsessed w/ lifetime exposures lol (ex. Blue light exposure)

60
Q

Explain
“Without exposure, there is no risk”

A

Risk will always be present, but our exposures vary.
* Variability across popu = diff exposures (individuals, geography, and time)
* Substances move across the environment

So, we use exposure defaults

61
Q

Define
Exposure Defaults
Why do we use them, when exposures vary?

A

assumptions about common exposure patterns
* Ex. an average adult drinks 2L water per day and breathes 22 cu. meters of air per day
* We make the generalization so that it’s easier for policy

62
Q

Define
Risk Characterization

A

To synthesize the risk for a specific population

63
Q

List
Goals of Risk Characterization
3

A
  1. Make judgement on risk to population
  2. Characterize uncertainty
  3. Synthesize risk for a particular health effect from a particular substance.

Note
* Respond to original problem formulated
* Allow for separation of policy judgements from scientific findings.

64
Q

List
Methods of Risk Characterization

A
  1. Population cancer risk
  2. Bright Line
  3. Hazard Index
  4. Margin of Exposure
65
Q

Explain
population cancer risk

A

Population cancer risk = CSF x LADD (Cancer Slope Factor, Lifetime Average Daily Dose)

[All are acceptable] Risk of:
* 1 in 1000000
* 1 in 100000
* 1 in 10000

Siyempre u want 1 in 1M but the others are fine; depends on manager

66
Q

Explain
Bright LIne

A

Standard intended to be clear and prevent subjective interpretation
Usually uses calculated RfD to guide risk management
< RfD is usually acceptable

67
Q

Explain
Hazard Index
What values are below and above concern?

A

Relationship bet. actual pop exposure and an established RfD
More specific way to compute acceptable risk (compared to just < RfD)
HI < 1 - below RfD; low risk
HI > 1 - above RfD; concern

68
Q

What is a risk manager’s job?

A
  • be a technical expert
  • must write v good executive summary (what politicians usually read)
69
Q

Explain
Margin of Exposure
What values are below and above concern?

A

Compares exposure to a NOAEL or BMDL
* MOE > 100 - relatively low risk
* MOE = 1 - risk level is of concern

70
Q

How does risk characterization help understand the greater risk of the most highly exposed?

A
  • usually on a normal distribution graph
    For avg population (mean or median of exposure distribution)
    For individuals at highest end of exposure distribution (90th/ 95th/ 99th percentiles)
  • at greater risk (aka need to consider them the most)